AOD9604
AOD9604 is a synthetic peptide that has been developed for its potential benefits in the field of obesity and weight management. It is a modified form of the Growth Hormone (GH) polypeptide, specifically the C-terminus fragment of the GH molecule which is responsible for the fat-reducing effects of GH, without its negative effects.
Overview[edit | edit source]
AOD9604 is a 15-amino acid peptide that was originally developed by Metabolic Pharmaceuticals Limited, an Australian company. It is a modified fragment of the human growth hormone molecule, specifically the C-terminus part of the molecule (amino acids 177-191). This fragment has been shown to stimulate lipolysis (the breakdown of fat) and inhibit lipogenesis (the transformation of nonfat food materials into body fat) both in laboratory testing and in animals and humans.
Mechanism of Action[edit | edit source]
The exact mechanism of action of AOD9604 is not fully understood. However, it is known that the peptide stimulates the Pituitary Gland to increase the production and release of growth hormone. This, in turn, stimulates the breakdown of fat (lipolysis) and inhibits the formation of new fat (lipogenesis).
Clinical Trials[edit | edit source]
AOD9604 has been tested in several clinical trials. In a double-blind, placebo-controlled clinical trial, the effects of AOD9604 on body weight and body composition were studied in obese and overweight adults. The results showed a significant reduction in body weight and body fat in the AOD9604 group compared to the placebo group.
Potential Uses[edit | edit source]
AOD9604 has potential uses in the treatment of obesity and weight management. It may also have potential in the treatment of osteoporosis, due to its ability to promote bone growth. However, more research is needed to confirm these potential uses.
Safety and Side Effects[edit | edit source]
In clinical trials, AOD9604 has been shown to be well tolerated with few side effects. The most common side effects reported were mild and included headache, nausea, and fatigue. However, as with any drug, there may be risks and side effects that are not yet known.
See Also[edit | edit source]
References[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
